Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pidala

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Bone Marrow Transplantation|June 6, 2017
Directionality of non-permissive HLA-DPB1 T-cell epitope group mismatches does not improve clinical risk stratification in 8/8 matched unrelated donor hematopoietic cell transplantationK Fleischhauer, K W Ahn, H L Wang, et al.
Bone Marrow Transplantation|April 4, 2017
Predictors of overall survival among patients treated with sirolimus/tacrolimus vs methotrexate/tacrolimus for GvHD preventionF Khimani, J Kim, L Chen, et al.
Bone Marrow Transplantation|January 29, 2013
Measurement of oral chronic GVHD: results from the Chronic GVHD ConsortiumN Treister, X Chai, B Kurland, et al.
Bone Marrow Transplantation|January 28, 2014
Investigator feedback about the 2005 NIH diagnostic and scoring criteria for chronic GVHDY Inamoto, M Jagasia, W A Wood, et al.
Bone Marrow Transplantation|September 3, 2013
Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic cell transplantation for adults with ALL in first remissionG Kunter, J B Perkins, J Pidala, et al.
Bone Marrow Transplantation|May 14, 2013
Comorbidity burden in patients with chronic GVHDW A Wood, X Chai, D Weisdorf, et al.
Bone Marrow Transplantation|December 8, 2009
Sirolimus for treatment of steroid-refractory acute graft-versus-host diseaseD Hoda, J Pidala, N Salgado-Vila, et al.
Bone Marrow Transplantation|August 7, 2012
Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilizationJ Pidala, J Kim, M Schell, et al.
Bone Marrow Transplantation|November 8, 2016
Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantationM A Kharfan-Dabaja, R Parody, J Perkins, et al.
Bone Marrow Transplantation|January 15, 2014
Clinical guide to fertility preservation in hematopoietic cell transplant recipientsS Joshi, B N Savani, E J Chow, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Bone Marrow Transplantation|June 6, 2017
Directionality of non-permissive HLA-DPB1 T-cell epitope group mismatches does not improve clinical risk stratification in 8/8 matched unrelated donor hematopoietic cell transplantationK Fleischhauer, K W Ahn, H L Wang, et al.
Bone Marrow Transplantation|April 4, 2017
Predictors of overall survival among patients treated with sirolimus/tacrolimus vs methotrexate/tacrolimus for GvHD preventionF Khimani, J Kim, L Chen, et al.
Bone Marrow Transplantation|January 29, 2013
Measurement of oral chronic GVHD: results from the Chronic GVHD ConsortiumN Treister, X Chai, B Kurland, et al.
Bone Marrow Transplantation|January 28, 2014
Investigator feedback about the 2005 NIH diagnostic and scoring criteria for chronic GVHDY Inamoto, M Jagasia, W A Wood, et al.
Bone Marrow Transplantation|September 3, 2013
Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic cell transplantation for adults with ALL in first remissionG Kunter, J B Perkins, J Pidala, et al.
Bone Marrow Transplantation|May 14, 2013
Comorbidity burden in patients with chronic GVHDW A Wood, X Chai, D Weisdorf, et al.
Bone Marrow Transplantation|December 8, 2009
Sirolimus for treatment of steroid-refractory acute graft-versus-host diseaseD Hoda, J Pidala, N Salgado-Vila, et al.
Bone Marrow Transplantation|August 7, 2012
Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilizationJ Pidala, J Kim, M Schell, et al.
Bone Marrow Transplantation|November 8, 2016
Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantationM A Kharfan-Dabaja, R Parody, J Perkins, et al.
Bone Marrow Transplantation|January 15, 2014
Clinical guide to fertility preservation in hematopoietic cell transplant recipientsS Joshi, B N Savani, E J Chow, et al.
Pageof 4